EP Patent

EP4491184A2 — Channel modulators

Assigned to Auckland Uniservices Ltd · Expires 2025-01-15 · 1y expired

What this patent protects

The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.

USPTO Abstract

The inventions relate to compositions and articles of manufacture comprising connexin modulators, pannexin modulators, gap junction modulators, hemichannel modulators, and pannexin channel modulators and their use, alone or in combination, in treating ocular and other disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP4491184A2
Jurisdiction
EP
Classification
—
Expires
2025-01-15
Drug substance claim
No
Drug product claim
No
Assignee
Auckland Uniservices Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.